Neogenomics Inc's FY2025 CEO total of $850K ranks #1243 of 1,423 complete filings; its 93:1 pay ratio ranks #676. Dollar rank is not ratio rank.
According to the same FY2025 complete-filing cohort used on the rankings boards (CEO total, median worker, and ratio all present). Median worker pay is $9,140. Industry placement uses the FY2025 SIC-87 peer cohort (#
8 of 18, 61st percentile - above the industry median pay ratio).
Figures come from Section 953(b) Dodd-Frank DEF 14A disclosures - not estimates.
View all Engineering & Management Services companies.
Dollar rank
#1243
$850K of 1,423 FY2025
Ratio rank
#676
93:1 of 1,423
Industry pct
61st
above the industry median pay ratio
How Neogenomics Inc ranks nationally
Neogenomics Inc CEO pay vs. every FY2025 complete filing
Total CEO compensation, the full national distribution, this company marked
$850,00013th percentilehigher than 13% of 1,423 companies
Each bar is a $2500K-wide band; taller bars hold more companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Neogenomics Inc vs. Engineering & Management Services peers
CEO total pay ($850K) against pay ratio (93:1) for Neogenomics Inc (marked) and its 5 closest same-industry peers, against the Engineering & Management Services industry median on both axes.
Neogenomics Inc vs. Engineering & Management Services peers, plotted against the industry's $11.4M median CEO total and 79:1 median pay ratio.
Neogenomics Inc: CEO total $850K, pay ratio 93:1:1.
Booz Allen Hamilton Holding Corp: CEO total $13.8M, pay ratio 87:1:1.
Fti Consulting, Inc: CEO total $10.2M, pay ratio 70:1:1.
ICF International, Inc.: CEO total $6.9M, pay ratio 68:1:1.
Rmr Group Inc.: CEO total $6.5M, pay ratio 67:1:1.
Medpace Holdings, Inc.: CEO total $11.4M, pay ratio 133:1:1.
Ratio bands among Engineering & Management Services peers
Exclusive CEO-to-median-worker bands across 17 complete latest-FY filings in SIC 87. Segments sum to the peer set, not this company's compensation pillar.
A component-level pay breakdown is not reported in Neogenomics Inc's structured SEC pay-ratio disclosure. See our methodology →
Filing-year trail · Neogenomics Inc
Complete DEF 14A pay-ratio filings for this CIK across FY2021–2025. Year-over-year deltas compare adjacent filing years only; incomplete dollar rows are omitted (same completeness gate as the hero figures).
Latest ratio
93:1
FY2025
vs prior FY
-67:1
from FY2021 160:1
CEO $ YoY
-93%
$850K latest
Filings shown
2
FY2021–2025
Neogenomics Inc CEO total compensation, median worker pay, and pay ratio by fiscal year from SEC EDGAR DEF 14A.
FY
CEO pay
Δ pay
Median worker
Pay ratio
Δ ratio
2021
$11.8M
-
$74,000
160:1
-
2025
$850K
-93%
$9,140
93:1
-67:1
Source: SEC EDGAR DEF 14A pay-ratio disclosures for CIK 1077183, FY2021–2025. Adjacent-year deltas only.
Industry Comparison - Engineering & Management Services
Neogenomics Inc's FY2025 CEO total $850K ranks #1243 of 1,423 complete filings (lower third by dollars). the CEO earned 93× the median employee ($9,140) in FY2025.
Median employee $9,140 (LOW-MED); MID · LIGHT stamps put about 93 median-wage years per CEO year.
CEO Total Pay
$850K
FY2025 Summary Compensation, below median
Pay Ratio
93:1
Near industry median
Neogenomics Inc in the lower-dollar third
Neogenomics Inc's FY2025 CEO total $850K ranks #1243 of 1,423 complete filings (lower third by dollars). The structured pay-ratio disclosure reports the total without line-item components. Engineering & Management Services (SIC 87) median ratio is 79:1 across 18 FY2025 filers; Neogenomics Inc's $850K CEO total is at or below the $11.4M industry median CEO pay.
SEC EDGAR DEF 14A for CIK 1077183, FY2025. Informational only, not investment advice. Verify on EDGAR.
Read our methodology
- how this data is sourced, computed, and verified.
Neogenomics Inc's FY2025 CEO total $850K ranks #1243 of 1,423 complete filings (lower third by dollars).
Read with Neogenomics Inc
ABS(ceo_total_comp) peers first, then a SIC pole and a stamp-branched guide - not a fixed Related strip.
This page stamps MID · LIGHT · LOW-MED.
Data sourced from SEC EDGAR DEF 14A for Neogenomics Inc (CIK 1077183), FY2025. See our methodology. Aggregated by PlainCEOPay as of August 2026.
Data currency:
Executive compensation from SEC EDGAR DEF 14A proxy statements through fiscal year 2025, compiled and last refreshed August 2026. See our methodology
for source dates and refresh cadence. Spot a figure that looks wrong?
Report a correction.
P
Compiled by PlainCEOPay, CEO compensation data publisher